MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 214 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $249,286 | -65.9% | 1,029 | -83.6% | 0.00% | -66.7% |
| Q1 2021 | $732,000 | -42.5% | 6,260 | -45.4% | 0.00% | -40.0% |
| Q4 2020 | $1,274,000 | -5.3% | 11,462 | +1.1% | 0.01% | -16.7% |
| Q3 2020 | $1,346,000 | -8.6% | 11,337 | -12.8% | 0.01% | -14.3% |
| Q2 2020 | $1,472,000 | +73.0% | 12,997 | +2.0% | 0.01% | +40.0% |
| Q1 2020 | $851,000 | +295.8% | 12,742 | +520.7% | 0.01% | +400.0% |
| Q2 2019 | $215,000 | – | 2,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |